Canada - TSX-V:TELO - CA87975M2085 - Common Stock
The current stock price of TELO.CA is 0.07 CAD. In the past month the price decreased by -6.67%. In the past year, price decreased by -69.57%.
Symbol | Company Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
EDT.CA | SPECTRAL MEDICAL INC | N/A | 485.89M | ||
FRX.CA | FENNEC PHARMACEUTICALS INC | N/A | 355.67M | ||
EPRX.CA | EUPRAXIA PHARMACEUTICALS INC | N/A | 264.31M | ||
TH.CA | THERATECHNOLOGIES INC | N/A | 210.13M | ||
HBP.CA | HELIX BIOPHARMA CORP | N/A | 116.10M | ||
WLLW.CA | WILLOW BIOSCIENCES INC | N/A | 100.71M | ||
MDNA.CA | MEDICENNA THERAPEUTICS CORP | N/A | 88.41M | ||
BLU.CA | BLUENERGIES LTD | N/A | 82.42M | ||
NRX.CA | NUREXONE BIOLOGIC INC | N/A | 72.01M | ||
MSCL.CA | SATELLOS BIOSCIENCE INC | N/A | 67.23M | ||
COV.CA | COVALON TECHNOLOGIES LTD | 16.92 | 60.32M | ||
SVA.CA | SERNOVA BIOTHERAPEUTICS INC | N/A | 47.21M |
Telo Genomics Corp. is a molecular diagnostics company, which engages in the development of telomere analysis platforms in the industry. The company is headquartered in Toronto, Ontario. The company went IPO on 2012-02-15. Its technologies utilize a multi-step process that involves capturing sample cells from blood or tissue, labeling, 3D formatting, processing and analyzing with TeloView. Its technologies are based on single cell biology. TeloView is a software platform, which is used to quantify specific features of each patient’s telomeres. The company quantifies six specific biological and structural features of telomeres and builds a score for each patient to assess their risk of disease progression and potential treatment response. TeloView helps in capturing the heterogeneity and complexity of cancers with relatively small sample sizes in clinical studies. Its initial lead includes multiple myeloma, prostate cancer and Alzheimer's disease.
TELO GENOMICS CORP
Mars Centre, 101 College St Suite 200
TORONTO ONTARIO M5G 1L7 CA
CEO: Sherif Louis
Employees: 0
Phone: 14166738487
The current stock price of TELO.CA is 0.07 CAD. The price decreased by -6.67% in the last trading session.
The exchange symbol of TELO GENOMICS CORP is TELO and it is listed on the TSX Venture Exchange exchange.
TELO.CA stock is listed on the TSX Venture Exchange exchange.
TELO GENOMICS CORP (TELO.CA) has a market capitalization of 7.03M CAD. This makes TELO.CA a Nano Cap stock.
TELO GENOMICS CORP (TELO.CA) currently has 0 employees.
TELO GENOMICS CORP (TELO.CA) has a resistance level at 0.08. Check the full technical report for a detailed analysis of TELO.CA support and resistance levels.
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
TELO.CA does not pay a dividend.
TELO GENOMICS CORP (TELO.CA) will report earnings on 2025-10-23.
TELO GENOMICS CORP (TELO.CA) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.03).
ChartMill assigns a fundamental rating of 2 / 10 to TELO.CA. While TELO.CA has a great health rating, there are worries on its profitability.
Over the last trailing twelve months TELO.CA reported a non-GAAP Earnings per Share(EPS) of -0.03. The EPS increased by 25.81% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | N/A | ||
ROA | -186.84% | ||
ROE | -232.51% | ||
Debt/Equity | 0 |